SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem India informs about non applicability of statement of deviations or variations

23 Oct 2025 Evaluate
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Syschem India confirmed that the requirement for submission of the statement of deviation or Variations is not applicable to the Company as: ‘The Company has not raised any funds through public issue, Preferential issue, qualified institutional Placement(QIP), etc. during the quarter ending 30th September, 2025 and there is no instance of deviation or variation in the use of proceeds from the earlier issue’. 

The above information is a part of company’s filings submitted to BSE.  

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×